Indica Labs Updates Breast IHC AI Suite

Indica Labs has announced an update to their Breast IHC AI suite, which now includes functionality for the detection of low and ultralow HER2 expression in breast cancer. Breast IHC AI is a suite of algorithms for performing WSI scoring of IHC-stained invasive primary breast carcinoma tissue sections, and it now includes an upgraded HER2 algorithm for detection of HER2 expression at any level, including low and ultralow! Check out our updated brochure to learn about this powerful new capability and how Breast IHC AI empowers pathologists by standardizing biomarker evaluation, increasing workflow efficiency, and complementing expertise.

Download

Reach out to Indica at info@indicalab.com with any questions or to learn more!

SOURCE: Indica Labs